We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MOS:NYSEMosaic Company (The) Analysis

Data as of 2026-08-30 - not real-time

$23.60

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The Mosaic Company trades at $23.60, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 6.6%. Momentum indicators put RSI at 55.4 (neutral) with MACD reading bullish. Price has been bracketed by support at $20.82 and resistance at $25.20.
The shares look undervalued at 14.7 times earnings, though no sector average was available for comparison. Analyst price targets sit 12.2% above the current price. Revenue is contracting at 6.0% on a -5.2% profit margin. The 3.70% dividend yield looks stretched against payout coverage.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 39.7%, a beta of 0.78 and a maximum drawdown of 44.8%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.

Top Market Events

Updated Jul 15, 2026 0 TAMPA, Fla., July 15, 2026 /PRNewswire/ -- The Mosaic Company NYSE: MOS plans to release second...Despite phosphate production cuts and elevated input costs, The Mosaic Co MOS leverages strong liquidity and cost...The Mosaic Company NYSE: MOS announced today that its Board of Directors declared a quarterly dividend of $0.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 24.53
  • MACD momentum is positive
  • 30-day price change of +6.6%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Dividend yield of 3.70% looks stretched against payout coverage
  • Trading below the 200-day average of 24.53
  • Analyst targets imply +12.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Dividend yield of 3.70% looks stretched against payout coverage
  • Negative profit margin of -5.2%
  • Analyst targets imply +12.2% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-6.00%
Profit Margin-5.21%
P/E Ratio14.7
ROE-5.07%
ROA1.24%
Debt/Equity52.25
P/B Ratio0.7
Op. Cash Flow$444.0M
Free Cash Flow$-746275008

Technical Analysis

TrendNeutral
RSI55.4
Support$20.82
Resistance$25.20
MA 20$22.96
MA 50$22.38
MA 200$24.53
MACDBullish
VolumeStable
Fear & Greed Index95.66

Valuation

Target Price$26.47
Upside/Downside12.15%
GradeUndervalued
TypeValue
Dividend Yield3.70%

Risk Assessment

Beta0.78
Volatility39.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.